- Home
- TRNS vs COLL Comparison
TRNS vs COLL Comparison
Compare TRNS & COLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRNS
- COLL
- Stock Information
- Founded
- TRNS 1964
- COLL 2002
- Country
- TRNS United States
- COLL United States
- Employees
- TRNS N/A
- COLL N/A
- Industry
- TRNS Electrical Products
- COLL Biotechnology: Pharmaceutical Preparations
- Sector
- TRNS Industrials
- COLL Health Care
- Exchange
- TRNS Nasdaq
- COLL Nasdaq
- Market Cap
- TRNS 1.1B
- COLL 1.1B
- IPO Year
- TRNS N/A
- COLL 2015
- Fundamental
- Price
- TRNS $103.42
- COLL $29.58
- Analyst Decision
- TRNS Strong Buy
- COLL Strong Buy
- Analyst Count
- TRNS 4
- COLL 6
- Target Price
- TRNS $119.75
- COLL $42.00
- AVG Volume (30 Days)
- TRNS 102.8K
- COLL 440.1K
- Earning Date
- TRNS 10-28-2024
- COLL 11-07-2024
- Dividend Yield
- TRNS N/A
- COLL N/A
- EPS Growth
- TRNS 77.19
- COLL 757.11
- EPS
- TRNS 1.98
- COLL 2.16
- Revenue
- TRNS $270,612,000.00
- COLL $599,245,000.00
- Revenue This Year
- TRNS $9.56
- COLL $13.02
- Revenue Next Year
- TRNS $6.00
- COLL $18.01
- P/E Ratio
- TRNS $52.26
- COLL $13.68
- Revenue Growth
- TRNS 11.42
- COLL 9.62
- 52 Week Low
- TRNS $89.74
- COLL $25.07
- 52 Week High
- TRNS $147.12
- COLL $42.29
- Technical
- Relative Strength Index (RSI)
- TRNS 38.56
- COLL 26.96
- Support Level
- TRNS $105.23
- COLL $29.69
- Resistance Level
- TRNS $110.59
- COLL $35.62
- Average True Range (ATR)
- TRNS 4.46
- COLL 1.41
- MACD
- TRNS 0.43
- COLL -0.39
- Stochastic Oscillator
- TRNS 45.27
- COLL 6.36
About TRNS Transcat Inc.
Transcat Inc is involved in providing calibration and laboratory instrument services and distribution of test, measurement, and control instrumentation. Its product and services portfolio consists of calibration instruments, dimensional measuring tools, Electrical test instruments, pressure measurement, etc. The firm has Service and Distribution operating segments. It derives the majority of its revenues from the Service segment. The firm promotes and sells its products under brand names such as Estech, FLIR, Fluke, Keysight, and Megger among others. It serves to pharmaceutical, industrial manufacturing, energy, and chemical process industries.
About COLL Collegium Pharmaceutical Inc.
Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of highly abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.